EMINENT announces Facility Enhancements, Global Expansion to Enhance Pharma Research & Manufacturing Capabilities

EMINENT, a global CDMO, announces facility expansions and upgrades, strengthening its leadership in Pharmaceutical manufacturing and clinical trial support. EMINENT Services Corporation a global CDMO subsidiary of EMINENT Life Sciences, a prominent leader in clinical trial support, is pleased to announce significant facility expansion and upgrades, reinforcing its leadership in pharmaceutical manufacturing and clinical trial support. In […]
EMINENT Services Corporation Expands Support for Food Allergy Research with Cost-Effective Solutions

EMINENT Services Corporation, a global CDMO subsidiary of EMINENT Life Sciences, a recognized leader in clinical trial support, proudly announces its continued commitment to advancing food allergy research. As food allergies reach epidemic proportions in the United States, EMINENT is driving innovation by supporting groundbreaking clinical trials while delivering critical services at a fraction of the cost […]
EMINENT supports Multiple Groundbreaking Studies Exploring the Role of Semaglutide and Tirzepatide in Clinical Trials

EMINENT contributes to numerous pioneering studies investigating the role of Semaglutide and Tirzepatide in clinical trials.
EMINENT Enhances Capabilities and Offers New Cost-Effective Solutions

EMINENT Services Corporation, a prominent leader in clinical trial support, proudly announces the enhancement of customer-tailored budget solutions aimed at aiding Contract Research Organizations (CROs), academic researchers, government agencies, and pharmaceutical investigators in navigating budget-conscious protocol deployments.
EMINENT Services Corporation partners with CIAN Diagnostics

EMINENT Services Corporation partners with CIAN Diagnostics and launches EMINENT Life Sciences to Enhance Healthcare Solutions.